Product image of Nanocis (Rhenium Sulfide) supplied by GNH India

Nanocis

Active Ingredient:
Rhenium Sulfide
Origin:
EU

Nanocis (Rhenium Sulfide)

Rhenium Sulfide, the active ingredient in Nanocis, is a compound presented as a subcutaneous preparation for investigational use. It is being evaluated in clinical settings for its potential therapeutic properties. GNH India supplies Nanocis as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Cis Bio Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Nanocis is an investigational agent studied in the following contexts:

  • Oncology research: potential antitumor activity is being evaluated in early‑phase trials.
  • Immunomodulation studies: explored for its effects on immune cell signaling.
  • Rare disease investigations: assessed as a candidate for conditions with unmet medical need.

How It Works

  • The precise pharmacological mechanism of Rhenium Sulfide has not been fully disclosed in public literature. Preliminary data suggest it may interact with cellular metal‑binding pathways and influence redox processes, which could modulate disease‑related signaling cascades. Ongoing research aims to clarify its target receptors and downstream effects.

Side Effects

Adverse reactions reported in early studies are limited and not fully characterized.

Common Side Effects

  • Injection site pain: mild discomfort at the subcutaneous injection site.
  • Transient erythema: temporary redness around the injection area.
  • Mild headache: occasional short‑lasting headache.

Serious or Rare Side Effects

  • Hypersensitivity reaction: signs of allergy such as rash, swelling, or breathing difficulty.
  • Unexplained fever: persistent elevated temperature without infection.
  • Laboratory abnormalities: rare changes in liver enzymes or blood counts.

Precautions & Warnings

When handling Nanocis, consider the following precautions:

  • Patient assessment: evaluate baseline health status before administration.
  • Allergy screening: confirm no known hypersensitivity to metal‑based compounds.
  • Monitoring: observe patients for immediate post‑injection reactions.
  • Concomitant therapy review: assess other investigational agents for overlapping toxicity.
  • Storage: Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Potential drug interactions have not been comprehensively documented.

Major Interactions (Avoid)

  • Immunosuppressants: may amplify immunomodulatory effects.
  • Metal chelators: could reduce the bioavailability of Rhenium Sulfide.

Moderate Interactions (Monitor Closely)

  • Anticoagulants: monitor coagulation parameters.
  • Hepatotoxic drugs: watch for additive liver enzyme changes.
  • Vaccines: assess timing to avoid overlapping immune activation.

Frequently Asked Questions

Nanocis is an investigational product containing Rhenium Sulfide that is being studied in clinical research for potential antitumor activity, immunomodulation, and treatment of rare diseases with unmet medical needs.

Rhenium Sulfide is thought to interact with cellular metal‑binding pathways and influence redox balance, which may affect signaling cascades involved in disease processes. Exact targets are still under investigation.

The dosing regimen for Nanocis is determined by the prescribing investigator or clinician based on the specific study protocol and patient characteristics. No fixed dose can be stated publicly.

Safety data for Rhenium Sulfide in pregnancy or lactation are insufficient. Use is generally avoided unless the potential benefit justifies the potential risk, and it should be decided by a qualified healthcare professional.

To request Nanocis, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and import documentation.

Nanocis differs from many alternatives by its unique metal‑based composition (Rhenium Sulfide). While other agents may target specific receptors, Nanocis is being evaluated for broader redox‑modulating effects, which could offer a distinct therapeutic profile pending trial results.

Nanocis should be stored at 2‑8 °C, protected from light, and must not be frozen or shaken. Keep the product in its original packaging to maintain stability.

Nanocis is administered by subcutaneous injection, typically performed by a qualified healthcare professional in a clinical setting following the study protocol.

Serious risks include hypersensitivity reactions such as rash, swelling, or breathing difficulty, unexplained fever, and rare laboratory abnormalities affecting liver function or blood counts. Immediate medical attention is required if these occur.

Patients with known hypersensitivity to metal‑based compounds, those receiving conflicting investigational agents, or individuals for whom the risk outweighs potential benefit should not use Nanocis. Final eligibility is determined by the study investigator.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.